These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27862687)

  • 21. The natural history of the immune response to exogenous factor VIII in severe haemophilia A.
    Scandella D; Mondorf W; Klinge J
    Haemophilia; 1998 Jul; 4(4):546-51. PubMed ID: 9873792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A.
    Batty P; Moore GW; Platton S; Maloney JC; Palmer B; Bowles L; Pasi KJ; Rangarajan S; Hart DP
    Thromb Haemost; 2015 Oct; 114(4):804-11. PubMed ID: 26063073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody formation and specificity in Bethesda-negative brother pairs with haemophilia A.
    Klintman J; Hillarp A; Donfield S; Berntorp E; Astermark J
    Haemophilia; 2013 Jan; 19(1):106-12. PubMed ID: 22762454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients.
    Rampersad AG; Boylan B; Miller CH; Shapiro A
    Haemophilia; 2018 Sep; 24(5):807-814. PubMed ID: 30004159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of natural anti-factor VIII antibodies in plasma pools from healthy donors: use of rationally designed synthetic peptides.
    Di Giambattista M; Branckaert T; Laub R
    Biologicals; 2001; 29(3-4):229-32. PubMed ID: 11851320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Identification of IgG subclass and FVIII binding epitope of an acquired FVIII inhibitor in a bullous pemphigoid patient].
    Zuo WL; Zhang GS; Qing ZJ; Xu YX; Qin LX; Xu M
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):593-7. PubMed ID: 17278424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A mice.
    Shetty KA; Kosloski MP; Mager DE; Balu-Iyer SV
    Biopharm Drug Dispos; 2016 Oct; 37(7):409-420. PubMed ID: 27418232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralisation of factor VIII inhibitors by anti-idiotypes isolated from phage-displayed libraries.
    Schmidt A; Brettschneider K; Kahle J; Orlowski A; Becker-Peters K; Stichel D; Schulze J; Braner M; Tampé R; Schwabe D; Königs C
    Thromb Haemost; 2016 Jul; 116(1):32-41. PubMed ID: 27009573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.
    Yada K; Nogami K; Shima M
    Br J Haematol; 2013 Oct; 163(1):104-11. PubMed ID: 23889549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of factor VIII inhibitors.
    Shima M
    Int J Hematol; 2006 Feb; 83(2):109-18. PubMed ID: 16513528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epitope mapping of factor VIII inhibitor antibodies of Chinese origin.
    Huang CC; Shen MC; Chen JY; Hung MH; Hsu TC; Lin SW
    Br J Haematol; 2001 Jun; 113(4):915-24. PubMed ID: 11442484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chain.
    Laub R; Di Giambattista M; Fondu P; Brackmann HH; Lenk H; Saenko EL; Felch M; Scandella D
    Thromb Haemost; 1999 Jan; 81(1):39-44. PubMed ID: 9974372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-factor VIII inhibitor alloantibodies recognizing the A2 domain in the human factor VIII heavy chain poorly bind to porcine factor VIII.
    Sawamoto Y; Shima M; Tanaka I; Nakai H; Kamisue S; Scandella D; Yoshioka A
    Int J Hematol; 1997 Feb; 65(2):151-8. PubMed ID: 9071819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergic reaction in a cohort of haemophilia A patients using plasma-derived factor VIII (FVIII) concentrate is rare and not necessarily triggered by FVIII.
    Montalvão SA; Tucunduva AC; Siqueira LH; Sambo AL; Medina SS; Ozelo MC
    Haemophilia; 2015 Jul; 21(4):e281-5. PubMed ID: 25929310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response against serial infusion of factor VIII antigen through an implantable venous-access device system in haemophilia A mice.
    Madoiwa S; Kobayashi E; Kashiwakura Y; Sakata A; Yasumoto A; Ohmori T; Mimuro J; Sakata Y
    Haemophilia; 2012 May; 18(3):e323-30. PubMed ID: 22044430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.
    Boylan B; Rice AS; Dunn AL; Tarantino MD; Brettler DB; Barrett JC; Miller CH; ;
    J Thromb Haemost; 2015 Jan; 13(1):47-53. PubMed ID: 25354263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.
    Oomen I; Verhagen M; Miranda M; Allacher P; Beckers EAM; Blijlevens NMA; van der Bom JG; Coppens M; Driessens M; Eikenboom JCJ; Fijnvandraat K; Hassan S; van Heerde WL; Hooimeijer HL; Jansen JH; Kaijen P; Leebeek FWG; Meijer D; Paul H; Rijpma SR; Rosendaal FR; Smit C; van Vulpen LFD; Voorberg J; Schols SEM; Gouw SC
    Front Immunol; 2024; 15():1355813. PubMed ID: 38455035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restricted epitope specificity of anti-FVIII antibodies that appeared during a recent outbreak of inhibitors.
    Gilles JG; Peerlinck K; Arnout J; Vermylen J; Saint-Remy JM
    Thromb Haemost; 1997 May; 77(5):938-43. PubMed ID: 9184406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitor development in correlation to factor VIII genotypes.
    Oldenburg J; El-Maarri O; Schwaab R
    Haemophilia; 2002 Mar; 8 Suppl 2():23-9. PubMed ID: 11966849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.
    Pashov AD; Calvez T; Gilardin L; Maillère B; Repessé Y; Oldenburg J; Pavlova A; Kaveri SV; Lacroix-Desmazes S
    Haemophilia; 2014 Mar; 20(2):176-84. PubMed ID: 24118514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.